Skip to main content

Table 3 Number of significantly enriched GO terms (or pathways)

From: Comprehensive evaluation of matrix factorization methods for the analysis of DNA microarray gene expression data

(a) Leukemia dataset

Kmeans

SVD

PCA

ICA

NMF

SNMF

BSNMF

ALL

480

389

441

453

532

425

535

AML

85

262

223

222

167

266

280

Total

565

651

664

675

699

691

815

(b) Medulloblastoma dataset

Kmeans

SVD

PCA

ICA

NMF

SNMF

BSNMF

classic

517

373

467

479

388

456

599

desmoplastic

58

361

226

213

335

208

206

Total

575

734

693

692

723

664

805

(c) Fibroblast dataset

kmeans

SVD

PCA

ICA

NMF

SNMF

BSNMF

cluster1

52

45

71

47

57

41

128

cluster2

32

35

68

27

54

48

69

cluster3

48

24

63

61

37

75

50

cluster4

126

38

37

96

108

60

155

cluster5

54

63

60

33

65

68

102

Total

312

205

299

264

321

292

504

(d) Mouse dataset

kmeans

SVD

PCA

ICA

NMF

SNMF

BSNMF

cluster1

593

520

294

258

637

686

690

cluster2

27

61

107

114

38

28

56

Total

620

581

401

372

675

714

746

  1. Number of significantly enriched terms at α=0.05